Table 4.

Risk factors for relapse at the time of ASCT

Risk factor
Relapse <12 months after frontline therapy∗	27 (41%)
Refractory to frontline therapy	24 (36%)
Presence of extranodal involvement at relapse	23 (34%)
Partial response/stable disease pre-ASCT	22 (33%)
≥2 systemic treatments pre-ASCT	17 (25%)
Presence of B symptoms at relapse	13 (19%)
Number of risk factors
0	4 (6%)
≥1	63 (94%)
≥2	44 (66%)
≥3	14 (21%)

^∗One patient’s time to relapse was unknown; this patient has 3 other risk factors, and therefore, these data would not change their risk classification.